Drug Profile
XL 844
Alternative Names: EXEL-9844; XL844Latest Information Update: 17 Dec 2008
Price :
$50
*
At a glance
- Originator Exelixis
- Class Antineoplastics
- Mechanism of Action Checkpoint kinase 1 inhibitors; Checkpoint kinase 2 inhibitors; Checkpoint kinase inhibitors; Vascular endothelial growth factor receptor-2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Chronic lymphocytic leukaemia